Ascending Single/Multiple-Dose Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis

2019 ◽  
Author(s):  
Keyword(s):  
Ankylosing Spondylitis ◽  
Healthy Subjects ◽  
Multiple Dose ◽  
Phase 1 ◽  
Phase 1 Study

Abstract 2899: Multiple-dose phase 1 study of 3,3′-diindolylmethane (DIM): Pharmacokinetics and biological effects

2010 ◽  
Author(s):  
Gregory A. Reed ◽  
Jean M. Sunega ◽  
Kevin Latinis ◽  
John Gray ◽  
James A. Crowell ◽  
...  
Keyword(s):  
Multiple Dose ◽  
Biological Effects ◽  
Phase 1 ◽  
Phase 1 Study

A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects

2018 ◽  
Vol 107 (6) ◽  
pp. 1724-1730 ◽  
Author(s):  
Rajneet K. Oberoi ◽  
Weihan Zhao ◽  
Dilraj S. Sidhu ◽  
Rolando M. Viani ◽  
Roger Trinh ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Phase 1 ◽  
Phase 1 Study

SAT-341-MET409, an optimized sustained FXR agonist, was safe and well-tolerated in a 14-day phase 1 study in healthy subjects

2019 ◽  
Vol 70 (1) ◽  
pp. e789
Author(s):  
Hubert Chen ◽  
Karl Cremer ◽  
Eric Bischoff ◽  
Kyoung-Jin Lee ◽  
Rozalyn Littler ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Phase 1 ◽  
Phase 1 Study

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open-label, crossover phase 1 study

2015 ◽  
Vol 4 (5) ◽  
pp. 377-386 ◽  
Author(s):  
Selma Calcagnile ◽  
Corinna Lanzarotti ◽  
Michaela Gutacker ◽  
Verena Jakob-Rodamer ◽  
Klaus Peter Kammerer ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Phase 1 ◽  
Open Label ◽  
Phase 1 Study ◽  
Crossover Phase ◽  
Effect Of Food
Sign in / Sign up

Export Citation Format

Share Document